Reisner SL Poteat T Keatley J et al.

Global health burden and needs of transgender populations: a review.

Lancet. 388: 412-436https://doi.org/10.1016/s0140-6736(16)00684-x

Reporting sex, gender, or both in clinical research?.

JAMA. 316: 1863-1864https://doi.org/10.1001/jama.2016.16405

Sex differences in pharmacokinetics and pharmacodynamics.

Clin Pharmacokinet. 48: 143-157https://doi.org/10.2165/00003088-200948030-00001Bartz D Chitnis T Kaiser UB et al.

Clinical advances in sex- and gender-informed medicine to improve the health of all: a review.

JAMA Intern Med. 180: 574-583https://doi.org/10.1001/jamainternmed.2019.7194Mauvais-Jarvis F Bairey Merz N Barnes PJ et al.

Sex and gender: modifiers of health, disease, and medicine.

Lancet. 396: 565-582https://doi.org/10.1016/S0140-6736(20)31561-0

Care of transgender persons.

N Engl J Med. 381: 2451-2460https://doi.org/10.1056/NEJMcp1903650Liszewski W Peebles JK Yeung H Arron S

Persons of nonbinary gender - awareness, visibility, and health disparities.

N Engl J Med. 379: 2391-2393https://doi.org/10.1056/NEJMp1812005

Transgender population size in the United States: a meta-regression of population-based probability samples.

Am J Public Health. 107: e1-e8https://doi.org/10.2105/ajph.2016.303578Collin L Reisner SL Tangpricha V Goodman M.

Prevalence of transgender depends on the “case” definition: a systematic review.

J Sex Med. 13: 613-626https://doi.org/10.1016/j.jsxm.2016.02.001Downing JM Przedworski JM.

Health of transgender adults in the U.S., 2014-2016.

Am J Prev Med. 55: 336-344https://doi.org/10.1016/j.amepre.2018.04.045Collister D Pyne L Bhasin A et al.

Sex and gender considerations in randomized controlled trials in adults receiving chronic dialysis published in high impact journals: a meta-epidemiologic study.

Abstract, Canadian Society of Nephrology Annual General Meeting, May. Smyth B Haber A Trongtrakul K et al.

Representativeness of randomized clinical trial cohorts in end-stage kidney disease: a meta-analysis.

JAMA Intern Med. 179: 1316-1324https://doi.org/10.1001/jamainternmed.2019.1501Laprise C Cole K Sridhar VS et al.

Sex and gender considerations in transplant research: a scoping review.

Transplantation. 103: e239-e247https://doi.org/10.1097/TP.0000000000002828Tahhan AS Vaduganathan M Greene SJ et al.

Enrollment of older patients, women, and racial/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review.

JAMA Cardiol. 5: 714-722https://doi.org/10.1001/jamacardio.2020.0359Tahhan AS Vaduganathan M Greene SJ et al.

Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review.

JAMA Cardiol. 3: 1011-1019https://doi.org/10.1001/jamacardio.2018.2559Jin X Chandramouli C Allocco B Gong E Lam CSP Yan LL.

Women's participation in cardiovascular clinical trials from 2010 to 2017.

Circulation. 141: 540-548https://doi.org/10.1161/circulationaha.119.043594Van Spall HG Toren A Kiss A Fowler RA.

Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

JAMA. 297: 1233-1240https://doi.org/10.1001/jama.297.11.1233White Hughto JM Reisner SL Pachankis JE.

Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions.

Soc Sci Med. 147: 222-231https://doi.org/10.1016/j.socscimed.2015.11.010Wierckx K Elaut E Declercq E et al.

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.

Eur J Endocrinol. 169: 471-478https://doi.org/10.1530/EJE-13-0493Getahun D Nash R Flanders WD et al.

Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study.

Ann Intern Med. 169: 205-213https://doi.org/10.7326/m17-2785Dragon CN Guerino P Ewald E Laffan AM.

Transgender Medicare beneficiaries and chronic conditions: exploring fee-for-service claims data.

LGBT Health. 4: 404-411https://doi.org/10.1089/lgbt.2016.0208Scandurra C Mezza F Maldonato NM et al.

Health of non-binary and genderqueer people: a systematic review.

Front Psychol. 10: 1453https://doi.org/10.3389/fpsyg.2019.01453Townsend M Jaffer H Goldman L.

Adverse health outcomes in transgender people.

CMAJ. 189: E1046Levey AS Becker C Inker LA.

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

JAMA. 313: 837-846https://doi.org/10.1001/jama.2015.0602

James SE, Herman JL, Rankin S, et al. The report of the 2015 U.S. transgender survey. Accessed November 18, 2021. https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf

Shatzel JJ Connelly KJ DeLoughery TG.

Thrombotic issues in transgender medicine: a review.

Am J Hematol. 92: 204-208https://doi.org/10.1002/ajh.24593

Transgender-inclusive care.

CMAJ. 191: E79https://doi.org/10.1503/cmaj.180954

Promoting culturally competent care for the lesbian, gay, bisexual, and transgender population.

Am J Public Health. 91: 1731Baral SD Poteat T Strömdahl S Wirtz AL Guadamuz TE Beyrer C.

Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.

Lancet Infect Dis. 13: 214-222https://doi.org/10.1016/s1473-3099(12)70315-8Connelly PJ Marie Freel E Perry C et al.

Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults.

Hypertension. 74: 1266-1274https://doi.org/10.1161/hypertensionaha.119.13080Edmiston EK Donald CA Sattler AR Peebles JK Ehrenfeld JM Eckstrand KL.

Opportunities and gaps in primary care preventative health services for transgender patients: a systemic review.

Transgend Health. 1: 216-230https://doi.org/10.1089/trgh.2016.0019Hembree WC Cohen-Kettenis PT Gooren L et al.

Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline.

J Clin Endocrinol Metab. 102: 3869-3903https://doi.org/10.1210/jc.2017-01658

The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review.

Neuropsychiatr Dis Treat. 12: 1953-1966https://doi.org/10.2147/ndt.s95310Nobili A Glazebrook C Arcelus J.

Quality of life of treatment-seeking transgender adults: a systematic review and meta-analysis.

Rev Endocr Metab Disord. 19: 199-220https://doi.org/10.1007/s11154-018-9459-yWhite Hughto JM Reisner SL.

A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals.

Transgend Health. 1: 21-31https://doi.org/10.1089/trgh.2015.0008

Sex and gender diversity among transgender persons in Ontario, Canada: results from a respondent-driven sampling survey.

J Sex Res. 52: 1-14https://doi.org/10.1080/00224499.2014.893553Deutsch MB Bhakri V Kubicek K.

Effects of cross-sex hormone treatment on transgender women and men.

Obstet Gynecol. 125: 605-610https://doi.org/10.1097/aog.0000000000000692Defreyne J Vantomme B Van Caenegem E et al.

Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.

Andrology. 6: 446-454https://doi.org/10.1111/andr.12485Tangpricha V den Heijer M.

Oestrogen and anti-androgen therapy for transgender women.

Lancet Diabetes Endocrinol. 5: 291-300https://doi.org/10.1016/s2213-8587(16)30319-9Chan W Drummond A Kelly M.

Deep vein thrombosis in a transgender woman.

CMAJ. 189 ()https://doi.org/10.1503/cmaj.160408de Blok CJM Wiepjes CM Nota NM et al.

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.

BMJ. 365: l1652https://doi.org/10.1136/bmj.l1652Joint R Chen ZE Cameron S.

Breast and reproductive cancers in the transgender population: a systematic review.

BJOG. 125: 1505-1512https://doi.org/10.1111/1471-0528.15258Canner JK Harfouch O Kodadek LM et al.

Temporal trends in gender-affirming surgery among transgender patients in the United States.

JAMA Surg. 153: 609-616https://doi.org/10.1001/jamasurg.2017.6231

Urethral stricture after phalloplasty.

Transl Androl Urol. 8: 266-272https://doi.org/10.21037/tau.2019.05.08

Penile inversion vaginoplasty technique.

Urol Clin North Am. 46: 511-525https://doi.org/10.1016/j.ucl.2019.07.006Buncamper ME van der Sluis WB van der Pas RSD et al.

Surgical outcome after penile inversion vaginoplasty: a retrospective study of 475 transgender women.

Plast Reconstr Surg. 138: 999-1007https://doi.org/10.1097/PRS.0000000000002684Bairey Merz CN Dember LM Ingelfinger JR et al.

Sex and the kidneys: current understanding and research opportunities.

Nat Rev Nephrol. 15: 776-783https://doi.org/10.1038/s41581-019-0208-6Nitsch D Grams M Sang Y et al.

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.

BMJ. 346: f324https://doi.org/10.1136/bmj.f324Jafar TH Schmid CH Stark PC et al.

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Nephrol Dial Transplant. 18: 2047-2053https://doi.org/10.1093/ndt/gfg317Neugarten J Acharya A Silbiger SR.

Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

J Am Soc Nephrol. 11: 319-329Neugarten J Golestaneh L.

Gender and the prevalence and progression of renal disease.

Adv Chronic Kidney Dis. 20: 390-395https://doi.org/10.1053/j.ackd.2013.05.004Monster TB Janssen WM de Jong PE de Jong-van den Berg LT.

Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria.

Arch Intern Med. 161: 2000-2005https://doi.org/10.1001/archinte.161.16.2000Ahmed SB Hovind P Parving HH et al.

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

Diabetes Care. 28: 1988-1994https://doi.org/10.2337/diacare.28.8.1988Burgner A Hladunewich MA.

Contraception and CKD.

Clin J Am Soc Nephrol. 15: 563-565https://doi.org/10.2215/cjn.09770819Ramesh S Mann MC Holroyd-Leduc JM et al.

Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis.

Menopause. 23: 1028-1037https://doi.org/10.1097/gme.0000000000000657Ahmed SB Culleton BF Tonelli M et al.

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function.

Kidney Int. 74: 370-376https://doi.org/10.1038/ki.2008.205Kattah AG Suarez MLG Milic N et al.

Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis.

Menopause. 25: 625-634https://doi.org/10.1097/gme.0000000000001062Fung MM Poddar S Bettencourt R Jassal SK Barrett-Connor E.

A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.

Menopause. 18: 629-637https://doi.org/10.1097/gme.0b013e3181fca9c4Khurana KK Navaneethan SD Arrigain S Schold JD Nally Jr., JV Shoskes DA

Serum testosterone levels and mortality in men with CKD stages 3-4.

Am J Kidney Dis. 64: 367-374https://doi.org/10.1053/j.ajkd.2014.03.010

Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation.

Endocr Rev. 6: 151-182https://doi.org/10.1210/edrv-6-2-151Singh AB Norris K Modi N et al.

Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.

J Clin Endocrinol Metab. 86: 2437-2445https://doi.org/10.1210/jcem.86.6.7525Chiang JM Kaysen GA Segal M Chertow GM Delgado C Johansen KL.

Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.

Nephrol Dial Transplant. 34: 802-810https://doi.org/10.1093/ndt/gfy252Yilmaz MI Sonmez A Qureshi AR et al.

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

Clin J Am Soc Nephrol. 6: 1617-1625https://doi.org/10.2215/cjn.10681210Kyriazis J Tzanakis I Stylianou K et al.

Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.

Nephrol Dial Transplant. 26: 2971-2977https://doi.org/10.1093/ndt/gfq847Carrero JJ Qureshi AR Nakashima A et al.

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.

Nephrol Dial Transplant. 26: 184-190https://doi.org/10.1093/ndt/gfq397Gungor O Kircelli F Carrero JJ et al.

Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?.

Clin J Am Soc Nephrol. 5: 2018-2023https://doi.org/10.2215/cjn.03600410Carrero JJ Qureshi AR Parini P et al.

Low serum testosterone increases mortality risk among male dialysis patients.

J Am Soc Nephrol. 20: 613-620https://doi.org/10.1681/asn.2008060664Bello AK Stenvinkel P Lin M et al.

Serum testosterone levels and clinical outcomes in male hemodialysis patients.

Am J Kidney Dis. 63: 268-275https://doi.org/10.1053/j.ajkd.2013.06.010Lapi F Azoulay L Niazi MT Yin H Benayoun S Suissa S.

Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer.

JAMA. 310: 289-296https://doi.org/10.1001/jama.2013.8638Spanos C Bretherton I Zajac JD Cheung AS.

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: a systematic review.

World J Diabetes. 11: 66-77https://doi.org/10.4239/wjd.v11.i3.66Klaver M Dekker M de Mutsert R Twisk JWR den Heijer M.

Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis.

Andrologia. 49https://doi.org/10.1111/and.12660Collister D Krupka E et al.

The impact of gender affirming hormone therapy on kidney function biomarkers and glomerular filtration rate: a systematic review and meta-analysis.

Abstract, Canadian Society of Nephrology Annual General Meeting, May. Ginsburg ES Owen Jr., WF Greenberg LM Shea BF Lazarus JM Walsh BW

Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease.

J Clin Endocrinol Metab. 81: 4414-4417https://doi.org/10.1210/jcem.81.12.8954051Stehman-Breen C Anderson G Gibson D Kausz AT Ott S

Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis.

Kidney Int. 64: 290-294https://doi.org/10.1046/j.1523-1755.2003.00073.xMolnar AO Bota SE McArthur E et al.

Risk and complications of venous thromboembolism in dialysis patients.

Nephrol Dial Transplant. 33: 874-880https://doi.org/10.1093/ndt/gfx212Asscheman H Giltay EJ Megens JA de Ronde WP van Trotsenburg MA Gooren LJ.

A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.

Eur J Endocrinol. 164: 635-642https://doi.org/10.1530/eje-10-1038Go AS Chertow GM Fan D McCulloch CE Hsu CY.

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

N Engl J Med. 351: 1296-1305https://doi.org/10.1056/NEJMoa041031Kapoor P Luttrell BM Williams D.

The free androgen index is not valid for adult males.

J Steroid Biochem Mol Biol. 45: 325-326https://doi.org/10.1016/0960-0760(93)90350-6Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D.

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Ann Intern Med. 130 (): 461-470Bachman E Travison TG Basaria S et al.

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

J Gerontol A Biol Sci Med Sci. 69: 725-735https://doi.org/10.1093/gerona/glt154Ponce OJ Spencer-Bonilla G Alvarez-Villalobos N et al.

The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials.

J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-00404Quach K Lvtvyn L Baigent C et al.

The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis.

Am J Kidney Dis. 68: 591-598https://doi.org/10.1053/j.ajkd.2016.04.011

Prediction of creatinine clearance from serum creatinine.

Nephron. 16: 31-41https://doi.org/10.1159/000180580Inker LA Schmid CH Tighiouart H et al.

Estimating glomerular filtration rate from serum creatinine and cystatin C.

N Engl J Med. 367: 20-29https://doi.org/10.1056/NEJMoa1114248Fan L Levey AS Gudnason V et al.

Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals.

J Am Soc Nephrol. 26: 1982-1989https://doi.org/10.1681/asn.2014060607Stevens LA Claybon MA Schmid CH et al.

Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.

Kidney Int. 79: 555-562https://doi.org/10.1038/ki.2010.462Inker LA Levey AS Tighiouart H et al.

Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis.

Nephrol Dial Transplant. 33: 417-425https://doi.org/10.1093/ndt/gfx042Leung TK Luk AO So WY Lo MK Chan JC.

Development and validation of equations estimating glomerular filtration rates in Chinese patients with type 2 diabetes.

Kidney Int. 77: 729-735https://doi.org/10.1038/ki.2009.549Chen YW Chen HH Wang TE Chang CW Wu CJ.

Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis.

World J Gastroenterol. 17: 4532-4538https://doi.org/10.3748/wjg.v17.i40.4532Gagneux-Brunon A Delanaye P Maillard N et al.

Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort.

AIDS. 27: 1573-1581https://doi.org/10.1097/QAD.0b013e32835fac30Shaffi K Uhlig K Perrone RD et al.

Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients.

Am J Kidney Dis. 63: 1007-1018https://doi.org/10.1053/j.ajkd.2014.01.436

Creatinine-based GFR estimating equations in kidney transplant recipients.

Am J Kidney Dis. 64: 818https://doi.org/10.1053/j.ajkd.2014.05.027

GFR evaluation in living kidney donor candidates.

J Am Soc Nephrol. 28: 1062-1071https://doi.org/10.1681/asn.2016070790Price CP Newall RG Boyd JC.

Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review.

Clin Chem. 51 (): 1577-1586

Precision in GFR reporting: let's stop playing the race card.

Clin J Am Soc Nephrol. 15: 1201-1202https://doi.org/10.2215/cjn.00690120Levey AS Titan SM Powe NR Coresh J Inker LA.

Kidney disease, race, and GFR estimation.

Clin J Am Soc Nephrol. 15: 1203-1212https://doi.org/10.2215/cjn.12791019Hughes JP Emel L Hanscom B Zangeneh S.

Design issues in transgender studies.

J Acquir Immune Defic Syndr. 72: S248-S251https://doi.org/10.1097/qai.0000000000001077Owen-Smith AA Woodyatt C Sineath RC et al.

Perceptions of barriers to and facilitators of participation in health research among transgender people.

Transgend Health. 1: 187-196https://doi.org/10.1089/trgh.2016.0023Fredriksen-Goldsen KI Kim HJ McKenzie GL Krinsky L Emlet CA.

Plan of action for real-world translation of LGBTQ health and aging research.

LGBT Health. 4: 384-388https://doi.org/10.1089/lgbt.2017.0185Siskind RL Andrasik M Karuna ST et al.

Engaging transgender people in NIH-funded HIV/AIDS clinical trials research.

J Acquir Immune Defic Syndr. 72: S243-S247https://doi.org/10.1097/qai.0000000000001085